PF-06263276
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06263276, covering 2014-07-17 to 2014-07-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects [Phase 1]